Stop that glucose getting to heart!

Area of Science:

• Nuclear medicine and molecular imaging
• Cardiovascular disease diagnostics
• Metabolic imaging research

Background:

• 18F-FDG PET imaging is crucial for diagnosing cardiac inflammation and infections (e.g., sarcoidosis, myocarditis).
• Standardized protocols are needed, but patient-specific adaptations for suppressing myocardial glucose uptake are also vital.
• Current methods often involve prolonged fasting, which is not feasible for all patients.

Discussion:

• This study explores a 7-day ketogenic diet as a novel method to reduce physiological cardiac 18F-FDG uptake in a mouse model.
• Ketogenic diets alter substrate metabolism, shifting from glucose to fatty acids, potentially reducing myocardial glucose utilization.
• The findings suggest a viable alternative for patients who cannot tolerate fasting protocols for cardiac PET imaging.

Key Insights:

• A 7-day ketogenic diet significantly suppressed normal myocardial glucose uptake in mice.
• This dietary approach shows promise as an alternative to fasting for improving cardiac inflammation imaging.
• Successful translation to human studies could enhance diagnostic capabilities for various cardiac conditions.

Outlook:

• Further research is warranted to validate the efficacy and safety of ketogenic diets in human subjects for cardiac 18F-FDG PET imaging.
• Investigating optimal duration and composition of ketogenic diets for metabolic suppression in cardiac imaging is essential.
• This approach could broaden the applicability of 18F-FDG PET for diagnosing cardiac inflammatory and infectious diseases.